Order is for item(s) that are mission critical: reagents required to pre-screen blood products for donation. Failure to acquire these reagents would result in a total work stoppage.
Ended Awarded
- Contract number
- HT009025FG0830121
- Awardee
-
Abbott Laboratories Inc. UEI NH3LDK8CFAK7 Part of Abbott Laboratories Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $71,855
Award facts
- Contract value 100% obligated
- $71,855.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Chicago, IL 60064, USA
Award details come from SAM.gov/FPDS.
About this award
Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a Blanket Purchase Agreement (BPA) call valued at $71,855.24 by the Defense Health Agency on August 26, 2025, for mission-critical blood product screening reagents. The contract, which will be performed in North Chicago, Illinois, utilizes a firm fixed-price structure and is not subject to any set-aside designation, indicating full and open competition. These reagents are essential for pre-screening blood products for donation, with failure to acquire them resulting in total work stoppage at the performing location. This award is issued as a task order under an existing BPA vehicle, leveraging Abbott Laboratories' established position as a critical supplier of diagnostic products and laboratory solutions to federal healthcare agencies.
The Defense Health Agency relies on Abbott Laboratories' extensive portfolio of clinical laboratory testing capabilities and diagnostic equipment to support military healthcare operations. Abbott Laboratories holds multiple significant BPA and Indefinite Delivery Vehicle contracts across federal agencies, including substantial agreements with the Department of Veterans Affairs for immunochemistry and chemistry analyzer services valued in the tens of millions of dollars. The company's federal contracting history demonstrates consistent delivery of sophisticated medical diagnostic technologies, reagents, and clinical laboratory solutions across healthcare systems. This $71,855.24 award for blood product screening reagents supports the Defense Health Agency's critical transfusion services and blood banking operations through September 30, 2025.
Quick answers
Who was awarded contract HT009025FG0830121?
HT009025FG0830121 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on August 26, 2025.
How much is contract HT009025FG0830121 worth?
The government has obligated $71,855 on HT009025FG0830121.
Is contract HT009025FG0830121 an order under another contract?
Yes. HT009025FG0830121 is a BPA call under FA301624A0044, a blanket purchase agreement.
Was contract HT009025FG0830121 competed?
The extent of competition for HT009025FG0830121 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award